Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Fayetteville, AR
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated:  10/7/2013
Pfizer Investigational Site
mi
from
Houston, TX
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
A 12-Month Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures
Status: Enrolling
Updated: 10/7/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Children'S Hospital
mi
from
Aurora, CO
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Associated Neurologist of Southern CT, PC
mi
from
Fairfield, CT
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Associated Neurologist of Southern CT, PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Children's Hospital of Michigan
mi
from
Detroit, MI
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Gillette Children's Speciality Healthcare
mi
from
Saint Paul, MN
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Gillette Children's Speciality Healthcare
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Shriners Hospital for Children
mi
from
Portland, OR
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Shriners Hospital for Children
mi
from
Portland, OR
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Texas Scottish Rite Hospital for Children
mi
from
Dallas, TX
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Texas Scottish Rite Hospital for Children
mi
from
Dallas, TX
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Cook Children's Medical Center
mi
from
Fort Worth, TX
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated:  10/7/2013
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Dysport® Pediatric Lower Limb Spasticity Study
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral Palsy
Status: Enrolling
Updated: 10/7/2013
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)
A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)
Status: Enrolling
Updated:  10/7/2013
Physicians Committee for Responsible Medicine
mi
from
Washington,
A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)
A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)
Status: Enrolling
Updated: 10/7/2013
Physicians Committee for Responsible Medicine
mi
from
Washington,
Click here to add this to my saved trials
High Intensity Interval Training in Chronic Stroke
High Intensity Interval Training in Chronic Stroke
Status: Enrolling
Updated:  10/7/2013
University of Cincinnati
mi
from
Cincinnati, OH
High Intensity Interval Training in Chronic Stroke
High Intensity Interval Training in Chronic Stroke
Status: Enrolling
Updated: 10/7/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642 AM2)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Protocol No. P07642, Also Known as MK-8259-006-00).
Status: Enrolling
Updated:  10/8/2013
Clinical Research Facility
mi
from
Little Rock, AR
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642 AM2)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Protocol No. P07642, Also Known as MK-8259-006-00).
Status: Enrolling
Updated: 10/8/2013
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642 AM2)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Protocol No. P07642, Also Known as MK-8259-006-00).
Status: Enrolling
Updated:  10/8/2013
Clinical Research Facility
mi
from
Middleburg Heights, OH
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642 AM2)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Protocol No. P07642, Also Known as MK-8259-006-00).
Status: Enrolling
Updated: 10/8/2013
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Status: Enrolling
Updated:  10/10/2013
North Florida/South Georgia Veterans Health System
mi
from
Gainesville, FL
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Status: Enrolling
Updated: 10/10/2013
North Florida/South Georgia Veterans Health System
mi
from
Gainesville, FL
Click here to add this to my saved trials
An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth Athletes
Status: Enrolling
Updated:  10/13/2013
Noran Neurological Clinic
mi
from
Minneapolis, MN
An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth Athletes
Status: Enrolling
Updated: 10/13/2013
Noran Neurological Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-138
mi
from
Cullman, AL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-138
mi
from
Cullman, AL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-123
mi
from
Aurora, CO
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-123
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Bradenton, FL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-142
mi
from
Maitland, FL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-142
mi
from
Maitland, FL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-119
mi
from
Ormond Beach, FL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-119
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-120
mi
from
Pompano Beach, FL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-120
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-109
mi
from
Tampa, FL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-109
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Northbrook, IL
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Northbrook, IL
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-108
mi
from
Fort Wayne, IN
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-108
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Lenexa, KA
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-124
mi
from
Baltimore, MD
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-124
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-136
mi
from
Springfield, MA
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-136
mi
from
Springfield, MA
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Ann Arbor, MI
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Johnson City, NY
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Johnson City, NY
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-125
mi
from
New York, NY
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-125
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-141
mi
from
New York, NY
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-141
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Charlotte, NC
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Cincinnati, OH
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
Pittsburgh, PA
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site
mi
from
San Antonio, TX
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-133
mi
from
Salt Lake City, UT
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-133
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  10/15/2013
Osmotica Study Site-129
mi
from
Seattle, WA
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 10/15/2013
Osmotica Study Site-129
mi
from
Seattle, WA
Click here to add this to my saved trials
Predictors of Respiratory Failure Following Extubation in the SICU
Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)
Status: Enrolling
Updated:  10/17/2013
Massachusetts General Hospital
mi
from
Boston, MA
Predictors of Respiratory Failure Following Extubation in the SICU
Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)
Status: Enrolling
Updated: 10/17/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Effects of Exenatide on Body Weight in Patients With Hypothalamic Obesity
Status: Enrolling
Updated:  10/23/2013
Vanderbilt University
mi
from
Nashville, TN
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Effects of Exenatide on Body Weight in Patients With Hypothalamic Obesity
Status: Enrolling
Updated: 10/23/2013
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials